Insider trade

Inspiremd (NSPR): Chief Commercial Officer sold ~$4.7K

Shane Thomas Gleason, Chief Commercial Officer at Inspiremd, sold ~$4.7K of Inspiremd shares.

~$4.7K
Approx. value · 2,941 sh @ $1.59
1.08M
Holds after · shares reported
Traded
Feb 2, 2026
Filed
May 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 28, 2025InsiderOfficer sold ~$6.5K of NSPR shares in the open market
  2. Jan 29, 2025InsiderOfficer sold ~$9K of NSPR shares in the open market
  3. Jan 30, 2025InsiderOfficer sold ~$6.2K of NSPR shares in the open market
  4. Jan 31, 2025InsiderOfficer sold ~$25K of NSPR shares in the open market
  5. Feb 3, 2025InsiderOfficer sold ~$18K of NSPR shares in the open market
  6. Feb 4, 2025InsiderOfficer sold ~$13K of NSPR shares in the open market
  7. Feb 25, 2025InsiderOfficer sold ~$37K of NSPR shares in the open market
  8. May 23, 2025InsiderOfficer sold ~$6.2K of NSPR shares in the open market
  9. May 27, 2025InsiderOfficer sold ~$3.9K of NSPR shares in the open market
  10. May 29, 2025InsiderOfficer sold ~$9.4K of NSPR shares in the open market
  11. May 30, 2025InsiderOfficer sold ~$18K of NSPR shares in the open market
  12. Dec 4, 2025Insider · 13 days before an 8-KDirector purchased ~$19K of NSPR shares in the open market
  13. Dec 5, 2025Insider · 12 days before an 8-KDirector purchased ~$9.4K of NSPR shares in the open market
  14. Dec 9, 2025Insider · 8 days before an 8-KDirector purchased ~$4.9K of NSPR shares in the open market
  15. Dec 17, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 17, 2025, Kathryn Arnold, a Class III member of the board of directors of InspireMD, Inc. (the “Board” and the “Company”, respectively), a member of the compensation committee of the Board (the “Compensation Committee”), the nominating and corporate governance committee of the Board (the “Nominating Committee”) and the research and development committee of the Board (the “R&D Committee”), tendered her…”
  16. Jan 15, 2026InsiderOfficer sold ~$4.6K of NSPR shares in the open market
  17. Jan 16, 2026InsiderOfficer sold ~$3.6K of NSPR shares in the open market
  18. Jan 20, 2026InsiderOfficer sold ~$4.7K of NSPR shares in the open market
  19. Jan 21, 2026InsiderOfficer sold ~$29K of NSPR shares in the open market
  20. Jan 22, 2026InsiderOfficer sold ~$13K of NSPR shares in the open market
  21. Jan 27, 2026InsiderOfficer sold ~$8K of NSPR shares in the open market
  22. Jan 28, 2026InsiderOfficer sold ~$20K of NSPR shares in the open market
  23. Jan 29, 2026InsiderOfficer sold ~$8.3K of NSPR shares in the open market
  24. Jan 30, 2026InsiderOfficer sold ~$4.7K of NSPR shares in the open market
  25. Feb 2, 2026 · this disclosureInsiderOfficer sold ~$4.7K of NSPR shares in the open market

What came next

  1. Feb 2, 2026InsiderOfficer sold ~$3.2K of NSPR shares in the open market
  2. Feb 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 27, 2026, InspireMD, Inc. (the “ Company ”) provided a notice of dismissal to Andrea Tommasoli, the Company’s Chief Operating Officer. Mr. Tommasoli is employed by InspireMD Ltd., a wholly owned subsidiary of the Company, pursuant to an Employment Contract, dated November 2, 2020, governed by French law (the “ Employment Agreement ”).”
  3. Mar 18, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  4. Apr 3, 2026Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  5. May 4, 2026Company filing · Form 8-K · ResultsReported its results
  6. May 6, 2026Insider · 2 peopleInsiders: 2 purchases (~$20K)
  7. May 7, 2026Insider · 3 peopleInsiders: 3 purchases (~$198K)
  8. May 8, 2026Insider · Named in an 8-K 12 days laterDirector purchased ~$76K of NSPR shares in the open market
  9. May 11, 2026Insider · Named in an 8-K 9 days laterDirector purchased ~$12K of NSPR shares in the open market
  10. May 12, 2026Insider · 4 insiders in a week, 7th time since 2012CEO purchased ~$25K of NSPR shares in the open market
  11. May 13, 2026Insider · Named in an 8-K 7 days laterDirector purchased ~$12K of NSPR shares in the open market
  12. May 14, 2026Insider · Named in an 8-K 6 days laterDirector purchased ~$5.8K of NSPR shares in the open market
  13. May 19, 2026InsiderOfficer sold ~$23K of NSPR shares in the open market
  14. May 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 20, 2026, Mr. Paul Stuka notified InspireMD, Inc. (the “Company”) of his decision to not seek reelection as a Class I director of the Board of Directors of the Company (the “Board”) at the Company’s 2027 Annual Meeting of Stockholders (the “2027 Annual Meeting”) and to retire from the Board.”
  15. May 27, 2026Insider · Named in an 8-K 7 days earlierDirector purchased ~$18K of NSPR shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Inspiremd

For Inspiremd, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NSPR page.

Other recent filings by Shane Thomas Gleason, Chief Commercial Officer

The full history of Shane Thomas Gleason, Chief Commercial Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Inspiremd (NSPR) insider traded, and how much?

Shane Thomas Gleason, Chief Commercial Officer at Inspiremd, sold ~$4.7K of Inspiremd shares. 2,941 shares at $1.59.

When did it happen, and when was it made public?

Traded: Feb 2, 2026. Filed: May 21, 2026. That is 108 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Inspiremd recently?

For Inspiremd, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the NSPR page.

Does this mean NSPR stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Inspiremd

Everything OQRO holds on this company is on its NSPR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data